SALL4及其在非生殖细胞恶性肿瘤中的临床应用价值

摘要/Abstract

摘要： 婆罗双树样基因4（SALL4）在胚胎干细胞和肿瘤细胞的增殖、多能性维持方面发挥着重要作用。在完全分化的细胞中，SALL4基因的表达被沉默或者下调，而在多种非生殖细胞恶性肿瘤中SALL4基因被再次激活，表达上调，并且SALL4的表达水平常常与疾病的进程、治疗效果及预后相关。因此，SALL4的检测对于非生殖细胞恶性肿瘤的诊断以及病情监测具有重要意义。

关键词: 肿瘤, 诊断, 肿瘤标记, 生物学, 婆罗双树样基因4

Abstract: Sallike 4 (SALL4) plays an important role in promoting the cellular proliferation and maintaining the pluripotency of embryonic stem cells and tumor cells. In fully differentiated cells, the expression of SALL4 is silenced or downregulated. However, the expression of SALL4 is found to be restored or upregulated in a variety of nongerm cell tumors. Besides, the expression of SALL4 is often associated with disease progression, treatment effect and prognosis. Therefore, examining the expression level of SALL4 will be of great importance in the diagnosis of disease and monitoring the disease progression for nongerm cell tumors.

Key words: Neoplasms, Diagnosis, Tumor markers, biological, Sallike 4

陈园园, 叶园园, 徐枫, 李志臻, 刘颖斌, 韩宝三. SALL4及其在非生殖细胞恶性肿瘤中的临床应用价值[J]. 国际肿瘤学杂志, 2016, 43(2): 155-.

CHEN Yuan-Yuan, YE Yuan-Yuan, XU Feng, LI Zhi-Zhen, LIU Ying-Bin, HAN Bao-San. SALL4 and its clinical application value in nongerm cell tumors[J]. Journal of International Oncology, 2016, 43(2): 155-.

参考文献

1］ Tanimura N, Saito M, Ebisuya M, et al. Stemnessrelated factor Sall4 interacts with transcription factors Oct3/4 and Sox2 and occupies OctSox elements in mouse embryonic stem cells［J］. J Biol Chem, 2013, 288(7): 50275038. DOI:10.1074/jbc.M112.411173. ［2］ Yong KJ, Gao C, Lim JS, et al. Oncofetal gene SALL4 in aggressive hepatocellular carcinoma［J］. N Engl J Med, 2013, 368(24): 22662276. DOI:10.1056/NEJMoa1300297. ［3］ Zhang L, Yan Y, Jiang Y, et al. The expression of SALL4 in patients with gliomas: high level of SALL4 expression is correlated with poor outcome［J］. J Neurooncol, 2015, 121(2): 261268. DOI:10.1007/s1106001416464. ［4］ Han SX, Wang JL, Guo XJ, et al. Serum SALL4 is a novel prognosis biomarker with tumor recurrence and poor survival of patients in hepatocellular carcinoma［J］. J Immunol Res, 2014, 2014: 262385. DOI:10.1155/2014/262385. ［5］ Zeng SS, Yamashita T, Kondo M, et al. The transcription factor SALL4 regulates stemness of EpCAMpositive hepatocellular carcinoma［J］. J Hepatol, 2014, 60(1): 127134. DOI:10.1016/j.jhep.2013.08.024. ［6］ Forghanifard MM, Ardalan Khales S, JavdaniMallak A, et al. Stemness state regulators SALL4 and SOX2 are involved in progression and invasiveness of esophageal squamous cell carcinoma［J］. Med Oncol, 2014, 31(4): 922. DOI:10.1007/s1203201409227. ［7］ Cao D, Humphrey PA, Allan RW. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors［J］. Cancer, 2009, 115(12): 26402651. DOI:10.1002/cncr.24308. ［8］ Vasiljevic A, Szathmari A, Champier J, et al. Histopathology of pineal germ cell tumors［J］. Neurochirurgie, 2015, 61(2/3): 130137. DOI:10.1016/j.neuchi.2013.06.006. ［9］ Trinh DT, Shibata K, Hirosawa T, et al. Diagnostic utility of CD117, CD133, SALL4, OCT4, TCL1 and glypican3 in malignant germ cell tumors of the ovary［J］. J Obstet Gynaecol Res, 2012, 38(5): 841848. DOI:10.1111/j.14470756.2011.01798.x. ［10］ Bai S, Wei S, Ziober A, et al. SALL4 and SF1 are sensitive and specific markers for distinguishing granulosa cell tumors from yolk sac tumors［J］. Int J Surg Pathol, 2013, 21(2): 121125. DOI:10.1177/1066896912454567. ［11］ Cao D, Li J, Guo CC, et al. SALL4 is a novel diagnostic marker for testicular germ cell tumors［J］. Am J Surg Pathol, 2009, 33(7): 10651077. DOI:10.1097/PAS.0b013e3181a13eef. ［12］ Camparo P, Comperat EM. SALL4 is a useful marker in the diagnostic workup of germ cell tumors in extratesticular locations［J］. Virchows Arch, 2013, 462(3): 337341. DOI:10.1007/s0042801213535. ［13］ Yang F, Yao Y, Jiang Y, et al. Sumoylation is important for stability, subcellular localization, and transcriptional activity of SALL4, an essential stem cell transcription factor［J］. J Biol Chem, 2012, 287(46): 3860038608. DOI:10.1074/jbc.M112.391441. ［14］ Yang J, Corsello TR, Ma Y. Stem cell gene SALL4 suppresses transcription through recruitment of DNA methyltransferases［J］. J Biol Chem, 2012, 287(3): 19962005. DOI:10.1074/jbc.M111.308734. ［15］ Rao S, Zhen S, Roumiantsev S, et al. Differential roles of Sall4 isoforms in embryonic stem cell pluripotency［J］. Mol Cell Biol, 2010, 30(22): 53645380. DOI:10.1128/MCB.0041910. ［16］ Ardalan Khales S, Abbaszadegan MR, Abdollahi A, et al. SALL4 as a new biomarker for early colorectal cancers［J］. J Cancer Res Clin Oncol, 2015, 141(2): 229235. DOI:10.1007/s004320141808y. ［17］ Forghanifard MM, Moghbeli M, Raeisossadati R, et al. Role of SALL4 in the progression and metastasis of colorectal cancer［J］. J Biomed Sci, 2013, 20: 6. DOI:10.1186/14230127206. ［18］ Kobayashi D, Kuribayashi K, Tanaka M, et al. Overexpression of SALL4 in lung cancer and its importance in cell proliferation［J］. Oncol Rep, 2011, 26(4): 965970. DOI:10.3892/or.2011.1374. ［19］ Kobayashi D, Kuribayshi K, Tanaka M, et al. SALL4 is essential for cancer cell proliferation and is overexpressed at early clinical stages in breast cancer［J］. Int J Oncol, 2011, 38(4): 933939. DOI:10.3892/ijo.2011.929. ［20］ Deisch J, Raisanen J, Rakheja D. Immunohistochemical expression of embryonic stem cell markers in malignant rhabdoid tumors［J］. Pediatr Dev Pathol, 2011, 14(5): 353359. DOI:10.2350/10090902OA.1. ［21］ Venneti S, Le P, Martinez D, et al. Malignant rhabdoid tumors Express stem cell factors, which Relate to the expression of EZH2 and Id proteins［J］. Am J Surg Pathol, 2011, 35(10): 14631472. DOI:10.1097/PAS.0b013e318224d2cd. ［22］ Yoshida A, Asano N, Kawai A, et al. Differential SALL4 immunoexpression in malignant rhabdoid tumours and epithelioid sarcomas［J］. Histopathology, 2015, 66(2): 252261. DOI:10.1111/his.12460. ［23］ Ushiku T, Shinozaki A, Shibahara J, et al. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma［J］. Am J Surg Pathol, 2010, 34(4): 533540. DOI:10.1097/PAS.0b013e3181d1dcdd. ［24］ Ikeda H, Sato Y, Yoneda N, et al. αFetoproteinproducing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression［J］. Hum Pathol, 2012, 43(11): 19551963. DOI:10.1016/j.humpath.2011.11.022. ［25］ Oikawa T, Kamiya A, Zeniya M, et al. Sallike protein 4 (SALL4), a stem cell biomarker in liver cancers［J］. Hepatology, 2013, 57(4): 14691483. DOI:10.1002/hep.26159. ［26］ GonzalezRoibon N, Katz B, Chaux A, et al. Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors［J］. Hum Pathol, 2013, 44(7): 12931299. DOI:10.1016/j.humpath.2012.10.017. ［27］ Liu TC, Vachharajani N, Chapman WC, et al. SALL4 immunoreactivity predicts prognosis in Western hepatocellular carcinoma patients but is a rare event: a study of 236 cases［J］. Am J Surg Pathol, 2014, 38(7): 966972. DOI:10.1097/PAS.0000000000000218. ［28］ Momenzadeh D, Rahmanzadeh S, RezaeiTavirani M, et al. ZNF797 plays an oncogenic role in gastric cancer［J］. Genet Mol Res, 2014, 13(4): 84218427. DOI:10.4238/2014.October.20.18. ［29］ Jeong HW, Cui W, Yang Y, et al. SALL4, a stem cell factor, affects the side population by regulation of the ATPbinding cassette drug transport genes［J］. PLoS One, 2011, 6(4): e18372. DOI:10.1371/journal.pone.0018372. ［30］ Yanagihara N, Kobayashi D, Kuribayashi K, et al. Significance of SALL4 as a drug?resistant factor in lung cancer［J］. Int J Oncol, 2015, 46(4): 15271534. DOI:10.3892/ijo.2015.2866.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲. 血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊. 局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	袁健, 黄燕华. Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[4]	陈红健, 张素青. 血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[5]	郭泽浩, 张俊旺. PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[6]	张百红, 岳红云. 新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[7]	许凤琳, 吴刚. EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[8]	王盈, 刘楠, 郭兵. 抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[9]	张蕊, 褚衍六. 基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[10]	高凡, 王萍, 杜超, 褚衍六. 肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[11]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东. ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[12]	刘静, 刘芹, 黄梅. 基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[13]	杨琳, 路宁, 温华, 张明鑫, 朱琳. 炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[14]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝. 癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[15]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志. 宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.